Repare Therapeutics Inc. (NASDAQ:RPTX)

Stock Price: $16.35
+0.29 (1.81%)
Updated Nov 28, 2022 03:03 PM GMT+0000
Overview
Financials
Statistics
Profile
Chart
Market Cap 686.07M
Revenue 0
Gross Profit 0
Shares Out 41.96M
EPS (ttm)
PE Ratio 0.0000
Forward PE -25.7372
Dividend Rate (ttm) 0.0000
Dividend Yield 0.0000
Trading Day Nov 28
Last Price $16.35
Previous Close $16.06
Change ($) 0.29
Change (%) 1.81%
Day's Open 16.315
Day's Range Market Closed
Day's Volume 10.12K
52 Week Range 8.07 - 27.4

About Repare Therapeutics Inc.

Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair.

The Company's pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor currently in Phase 1/2 clinical development, as well as RP-6306, a CCNE1-SL inhibitor, and a Polθ inhibitor program.

News

Quick info

Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Employees
102
Website
reparerx.com
Ticker Symbol
RPTX
Reporting Currency
USD